Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Validating Non-invasive Measurements of Central Blood Pressure in Type 2 Diabetic Patients
A completed clinical trial validating non-invasive measurements of central blood pressure in adults with type 2 diabetes.
-
CLINICAL_TRIALS withdrawal · 2012-06-12Clinical Trial Update: Glycemic Response to Momordica Charantia in Type 2 Diabetes [Phase 2]
Phase 2 study evaluating the glycemic response to Momordica charantia in type 2 diabetes; the trial status is withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: A Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 Diabetes [Phase 1]
Phase 1 multiple ascending dose study of CAT-1004 in patients with Type 2 diabetes to evaluate safety, tolerability, and pharmacokinetics.
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients [Phase 3]
A Phase 3 clinical trial evaluating rosiglitazone in combination with insulin for Type 2 diabetes mellitus has completed enrollment/status; …
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes [Phase 1]
Phase 1 study evaluating potential pharmacokinetic interactions when metformin is taken with GSK189075 in adults with Type 2 diabetes has co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: A Single Dose Of GSK189075 Taken By Mouth Containing Small Amounts Of Radioactivity Studied In Healthy Male Volunteers [Phase 1]
Phase 1 study of a single oral dose of GSK189075 containing trace radioactivity in healthy male volunteers; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: The Glycemic Response Elicited by Beta-glucans of Different Physical Properties and Form [NA]
Update on a clinical trial evaluating the glycemic response to beta-glucans with different physical properties and forms in individuals with…
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: A Post Marketing Safety Study of Sitagliptin (JANUVIA®) (MK-0431-234)
This is a completed post-marketing safety study evaluating sitagliptin (JANUVIA) for type 2 diabetes, with results posted.
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: Screening Epidemiological Program on Compensation Evaluation of Diabetes Mellitus Type 2 (DMT2) Patients on Oral Anti-diabetic (OAD) Monotherapy and Physicians Satisfaction of Their Usage
A completed clinical trial update evaluating compensation strategies for patients with Type 2 diabetes mellitus on oral antidiabetic monothe…
-
CLINICAL_TRIALS research · 2012-06-04Clinical Trial Update: In-patient Study in Patients With Type 2 Diabetes Mellitus [Phase 1]
This update notes the completion of a Phase 1 inpatient clinical trial in patients with Type 2 diabetes mellitus sponsored by GlaxoSmithKlin…
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus [Phase 2]
A Phase 2 clinical trial evaluating GW677954 in combination with insulin for type 2 diabetes was terminated.
-
FDA approval · 2012-06-01FDA Approved: GLIMEPIRIDE — Supplemental Application (Accord Healthcare Inc)
The FDA approved a supplemental application for glimepiride by Accord Healthcare Inc.
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: Impact of Liraglutide on Sensory Perception, Sensory Specific Satiety, Liking and Wanting in Type 2 Diabetic Patients [NA]
A completed clinical trial update examining the effects of liraglutide on sensory perception, sensory-specific satiety, liking and wanting i…
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: Research on the Nature, Diagnosis, and Treatment of Obesity and Diabetes
A completed Rockefeller University clinical trial investigating the nature, diagnosis, and treatment of obesity and diabetes.
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: Lifestyle Modification for Type 2 Diabetes Prevention in Overweight Youth [NA]
A completed clinical trial evaluated lifestyle modification as a strategy to prevent Type 2 diabetes in overweight youth.
-
FDA approval · 2012-05-31FDA Approved: GLIMEPIRIDE — Supplemental Application (Solco Healthcare U.S., LLC)
The FDA approved a supplemental application for Solco Healthcare U.S., LLC to market a generic version of glimepiride. Glimepiride is used t…
-
CLINICAL_TRIALS research · 2012-05-31Clinical Trial Update: Molecular Mechanisms of Type 2 Diabetes Mellitus [Phase 4]
The document reports the completion of a Phase 4 clinical trial focused on the molecular mechanisms of Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: A Study of Absorption, Metabolism, Excretion and Mass Balance After a Single Dose Administration of MK-0941 (MK-0941-016)(COMPLETED) [Phase 1]
Phase 1 pharmacokinetic study evaluating absorption, metabolism, excretion and mass balance after a single dose of MK-0941 in subjects with …
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: "Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients" [NA]
This completed clinical trial from University of Sao Paulo General Hospital evaluated the effect of a dipeptidyl peptidase-4 (DPP-4) inhibit…
-
CLINICAL_TRIALS trial_result · 2012-05-25Clinical Trial Update: A Study of Multiple Increasing Doses of LY2409021 in Participants With Type 2 Diabetes [Phase 1]
A Phase 1 dose-escalation study of LY2409021 in participants with type 2 diabetes mellitus has been completed.
-
CLINICAL_TRIALS trial_result · 2012-05-25Clinical Trial Update: A First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 Diabetes [Phase 1]
A first-in-human Phase 1 study of LY2409021 in healthy participants and participants with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-24Clinical Trial Update: Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy. [Phase 3]
Phase 3 trial update showing the efficacy of lapaquistat acetate in subjects with Type 2 diabetes mellitus who are on lipid-lowering therapy…
-
CLINICAL_TRIALS trial_result · 2012-05-23Clinical Trial Update: A Study Of PF-05190457 In Healthy Volunteers And Type-2 Diabetic Patients [Phase 1]
A Phase 1 study evaluating PF-05190457 in healthy volunteers and individuals with Type 2 diabetes has been terminated.
-
FDA approval · 2012-05-22FDA Approved: TRADJENTA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for TRADJENTA (linagliptin) filed by Boehringer Ingelheim Pharmaceuticals, Inc., resulting in update…
-
CLINICAL_TRIALS trial_result · 2012-05-21Clinical Trial Update: Efficacy and Safety Study of SYR-619 in Treating Subjects With Type 2 Diabetes Mellitus [Phase 2]
SYR-619, evaluated for Type 2 diabetes mellitus in a Phase 2 trial sponsored by Takeda, has been terminated. No efficacy or safety results a…